Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-06-02

FDA Approved: DIVALPROEX SODIUM — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved Aurobindo Pharma Limited's original ANDA for divalproex sodium, enabling a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIVALPROEX SODIUM (divalproex sodium)

Snippet

ORIG AP for DIVALPROEX SODIUM (DIVALPROEX SODIUM)